VITALIS PHARMA AS

0160 OSLO

Finances

Share Ownership

Return on Equity

3 991,09 %

Current Ratio

1,1

Debt-to-Equity Ratio

66,59

Key figures (NOK)	2022	2021	2020	2019
Revenue	103 832 000	99 054 000	100 019 000	52 673 000
Net Income	20 594 000	13 370 000	16 570 000	10 736 000
Total Assets	42 487 000	56 905 000	48 286 000	33 796 000
Total Equity	516 000	2 553 000	378 000	366 000

Income (NOK)	2022	2021	2020	2019
Revenue	103 832 000	99 054 000	100 019 000	52 673 000
Expenditure	76 693 000	81 994 000	78 494 000	39 977 000
Operating Profit	27 139 000	17 060 000	21 524 000	12 696 000
Financial Income	301 000	500 000	242 000	34 000
Financial Costs	320 000	387 000	526 000	66 000
Financial Balance	−19 000	113 000	−284 000	−32 000
Earnings Before Tax	27 120 000	17 173 000	21 240 000	12 664 000
Tax	6 527 000	3 803 000	4 670 000	1 928 000
Net Income	20 594 000	13 370 000	16 570 000	10 736 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	34 098 000	37 966 000	31 347 000	20 548 000
Total Current Assets	8 390 000	18 939 000	16 939 000	13 248 000
Total Assets	42 487 000	56 905 000	48 286 000	33 796 000
Total Retained Equity	−1 256 000	781 000	−1 394 000	−1 406 000
Total Equity	516 000	2 553 000	378 000	366 000
Total Long-Term Debt	34 361 000	23 336 000	17 002 000	17 124 000
Total Current Debt	7 610 000	31 016 000	30 907 000	16 306 000
Total Equity and Debt	42 487 000	56 905 000	48 286 000	33 796 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	103 832 000	99 054 000	100 019 000	52 673 000
Other Income	0	0	0	0
Revenue	103 832 000	99 054 000	100 019 000	52 673 000
Cost of Goods Sold	62 502 000	70 879 000	71 806 000	31 444 000
Salary Costs	3 344 000	3 640 000	2 867 000	239 000
Depreciation	20 000	17 000	7 000	0
Impairment	0	0	0	0
Expenditure	76 693 000	81 994 000	78 494 000	39 977 000
Operating Profit	27 139 000	17 060 000	21 524 000	12 696 000
Financial Income	301 000	500 000	242 000	34 000
Financial Costs	320 000	387 000	526 000	66 000
Financial Balance	−19 000	113 000	−284 000	−32 000
Dividends	0	0	0	10 000 000
Net Income	20 594 000	13 370 000	16 570 000	10 736 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	76 000	75 000	65 000	0
Total Tangible Assets	76 000	75 000	65 000	0
Total Fiancial Fixed Assets	34 021 000	37 891 000	31 282 000	20 548 000
Total Fixed Assets	34 098 000	37 966 000	31 347 000	20 548 000
Stock	898 000	2 063 000	3 239 000	4 843 000
Total Investments	0	0	0	0
Cash, Bank	705 000	7 913 000	2 286 000	1 986 000
Total Current Assets	8 390 000	18 939 000	16 939 000	13 248 000
Total Assets	42 487 000	56 905 000	48 286 000	33 796 000
Total Equity	516 000	2 553 000	378 000	366 000
Short-Term Group Debt	0	15 335 000	21 228 000	766 000
Total Long-Term Debt	34 361 000	23 336 000	17 002 000	17 124 000
Creditors	5 505 000	14 161 000	7 448 000	3 315 000
Unpaid Taxes	234 000	215 000	230 000	180 000
Dividends	0	0	0	10 000 000
Other Current Debt	1 728 000	661 000	241 000	285 000
Total Current Debt	7 610 000	31 016 000	30 907 000	16 306 000
Total Equity and Debt	42 487 000	56 905 000	48 286 000	33 796 000

Financial indicators	2022	2021	2020	2019
Return on Equity	3 991,09 %	523,7 %	4 383,6 %	2 933,33 %
Debt-to-Equity Ratio	66,59	9,14	44,98	46,79
Operating Profit Margin	26,14 %	17,22 %	21,52 %	24,1 %
Current Ratio	1,1	0,61	0,55	0,81
Quick Ratio	1,25	0,65	0,61	1,16
Equity Ratio	0,01	0,04	0,01	0,01
Gross Profit Margin	39,8 %	28,44 %	28,21 %	40,3 %